Wilson’s disease is an autosomal-recessive disorder caused by mutation in the ATP7B gene. Absent or reduced function of ATP7B protein leads to decreased hepatocellular excretion of copper into bile. Subsequent copper accumulation, first in the liver but ultimately in the brain and other tissues, produces different clinical manifestations such as hepatic, neurological, hematological, ophthalmological, and psychiatric problems. Diagnosis is based on clinical suspicion, parameters of copper metabolism, ophthalmic examination (Kayser-Fleischer rings) and a liver biopsy. Genetic studies are of limited use. Early diagnosis and initiation of therapy with chelators and therapeutic plasma exchange therapy are essential for prognosis. Liver transplantation corrects the underlying pathophysiology and can be lifesaving in fulminant hepatic failure. Screening of siblings and 1st degree relatives of the patients is also important.
KeywordsCopper metabolism Kayser-Fleischer rings Wilson’s disease Chelating agents Liver transplantation
Unable to display preview. Download preview PDF.
- Demir D, Kaymakoglu S, Dincer D, et al. Problems Encountered In The Diagnosis Of Wilson’s Disease. T Klin Gastroenterohepatol 2000, 11:11–16(English abstract)Google Scholar